Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pierce

Showing results (391-400 of 548) with videos related to

Pageof 55
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2022
Theory of change and strategic priorities of the world federation of haemophiliaJennifer Laliberté, Donna Coffin, Assad Haffar, et al.
Frontiers in Veterinary Science|December 16, 2020
Loci Associated With Antibody Response in Feral Swine (<i>Sus scrofa</i>) Infected With <i>Brucella suis</i>Courtney F Pierce, Vienna R Brown, Steven C Olsen, et al.
Expert Review of Clinical Pharmacology|February 23, 2026
Factor-VIII mimetic bispecific antibodies for the treatment of hemophilia A: an updateVitória Eduarda Alves de Jesus, Douglas Lamounier de Almeida, Roberto Lúcio Muniz Júnior, et al.
Journal of Thrombosis and Haemostasis : JTH|December 17, 2020
Application of a hemophilia mortality framework to the Emicizumab Global Safety DatabaseFlora Peyvandi, Johnny N Mahlangu, Steven W Pipe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 2023
A foundation to better care: Target product profile for haemophilia and Von Willebrand disease point-of-care diagnostics in low-resource settingsJuliana Hagembe, Pierre Toulon, Assad Haffar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 8, 2024
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia AEmily Symington, Savita Rangarajan, Will Lester, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 13, 2026
Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia APriyanka Raheja, Savita Rangarajan, Will Lester, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 22, 2015
Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion proteinJustin McCue, Rashmi Kshirsagar, Keith Selvitelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1993
Adhesion onto and invasion into mammalian cells by mycoplasma penetrans: a newly isolated mycoplasma from patients with AIDSS C Lo, M M Hayes, H Kotani, et al.
Circulation|October 15, 1996
Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graftC Chen, S G Mattar, J D Hughes, et al.
Pageof 55

Showing results (391-400 of 548) with videos related to

Sort By:
Pageof 55
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 12, 2022
Theory of change and strategic priorities of the world federation of haemophiliaJennifer Laliberté, Donna Coffin, Assad Haffar, et al.
Frontiers in Veterinary Science|December 16, 2020
Loci Associated With Antibody Response in Feral Swine (<i>Sus scrofa</i>) Infected With <i>Brucella suis</i>Courtney F Pierce, Vienna R Brown, Steven C Olsen, et al.
Expert Review of Clinical Pharmacology|February 23, 2026
Factor-VIII mimetic bispecific antibodies for the treatment of hemophilia A: an updateVitória Eduarda Alves de Jesus, Douglas Lamounier de Almeida, Roberto Lúcio Muniz Júnior, et al.
Journal of Thrombosis and Haemostasis : JTH|December 17, 2020
Application of a hemophilia mortality framework to the Emicizumab Global Safety DatabaseFlora Peyvandi, Johnny N Mahlangu, Steven W Pipe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 1, 2023
A foundation to better care: Target product profile for haemophilia and Von Willebrand disease point-of-care diagnostics in low-resource settingsJuliana Hagembe, Pierre Toulon, Assad Haffar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 8, 2024
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia AEmily Symington, Savita Rangarajan, Will Lester, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 13, 2026
Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia APriyanka Raheja, Savita Rangarajan, Will Lester, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 22, 2015
Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion proteinJustin McCue, Rashmi Kshirsagar, Keith Selvitelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1993
Adhesion onto and invasion into mammalian cells by mycoplasma penetrans: a newly isolated mycoplasma from patients with AIDSS C Lo, M M Hayes, H Kotani, et al.
Circulation|October 15, 1996
Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graftC Chen, S G Mattar, J D Hughes, et al.
Pageof 55